The genus Acinetobacter consists of Gram‐negative obligate aerobic pathogens, including clinically relevant species, such as A. baumannii, which frequently cause hospital infections, affecting debilitated patients. The growing resistance to antimicrobial therapies shown by A. baumannii is reaching unacceptable levels in clinical practice, and there is growing concern that the serious conditions it causes may soon become incurable. New therapeutic possibilities are, therefore, urgently needed to circumvent this important problem. Synthetic cationic macromolecules, such as cationic antimicrobial peptides (AMPs), which act as membrane disrupters, could find application in these conditions. A lysine‐modified cationic polyester‐based dendrimer (G5‐PDK), capable of electrostat-ically interacting with bacterial surfaces as AMPs do, has been synthesized and characterized here. Given its chemical structure, similar to that of a fifth‐generation lysine containing dendrimer (G5K) with a different core, and previously found inactive against Gram‐positive bacterial species and En-terobacteriaceae, the new G5‐PDK was also ineffective on the species mentioned above. In contrast, it showed minimum inhibitory concentration values (MICs) lower than reported for several AMPs and other synthetic cationic compounds on Acinetobacter genus (3.2–12.7 μM). Time‐kill experiments on A. baumannii, A. pittii, and A. ursingii ascertained the rapid bactericidal effects of G5‐PDK, while subsequent bacterial regrowth supported its self‐biodegradability.

Bactericidal activity of a self‐biodegradable lysine‐containing dendrimer against clinical isolates of acinetobacter genus

Alfei S.;Caviglia D.;Piatti G.;Zuccari G.;Schito A. M.
2021-01-01

Abstract

The genus Acinetobacter consists of Gram‐negative obligate aerobic pathogens, including clinically relevant species, such as A. baumannii, which frequently cause hospital infections, affecting debilitated patients. The growing resistance to antimicrobial therapies shown by A. baumannii is reaching unacceptable levels in clinical practice, and there is growing concern that the serious conditions it causes may soon become incurable. New therapeutic possibilities are, therefore, urgently needed to circumvent this important problem. Synthetic cationic macromolecules, such as cationic antimicrobial peptides (AMPs), which act as membrane disrupters, could find application in these conditions. A lysine‐modified cationic polyester‐based dendrimer (G5‐PDK), capable of electrostat-ically interacting with bacterial surfaces as AMPs do, has been synthesized and characterized here. Given its chemical structure, similar to that of a fifth‐generation lysine containing dendrimer (G5K) with a different core, and previously found inactive against Gram‐positive bacterial species and En-terobacteriaceae, the new G5‐PDK was also ineffective on the species mentioned above. In contrast, it showed minimum inhibitory concentration values (MICs) lower than reported for several AMPs and other synthetic cationic compounds on Acinetobacter genus (3.2–12.7 μM). Time‐kill experiments on A. baumannii, A. pittii, and A. ursingii ascertained the rapid bactericidal effects of G5‐PDK, while subsequent bacterial regrowth supported its self‐biodegradability.
File in questo prodotto:
File Dimensione Formato  
ijms-22-07274.pdf

accesso aperto

Descrizione: Articolo Completo
Tipologia: Documento in versione editoriale
Dimensione 2.51 MB
Formato Adobe PDF
2.51 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11567/1050405
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 9
social impact